温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,汇文网负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。
网站客服:3074922707
TM_F_1439_
_03_2018
Designation:F143903(Reapproved 2018)Standard Guide forPerformance of Lifetime Bioassay for the TumorigenicPotential of Implant Materials1This standard is issued under the fixed designation F1439;the number immediately following the designation indicates the year oforiginal adoption or,in the case of revision,the year of last revision.A number in parentheses indicates the year of last reapproval.Asuperscript epsilon()indicates an editorial change since the last revision or reapproval.1.Scope1.1 This guide is intended to assist the biomaterials testinglaboratory in the conduct and evaluation of tumorigenicity teststo evaluate the potential for new materials to evoke a neoplasticresponse.The procedure is generally reserved only for thosematerials which have not previously been used for humanimplantation for a significant period of time.1.2 Assessment of tumorigenicity is one of several proce-dures employed in determining the biological response to amaterial as recommended in Practice F748.It is assumed thatthe investigator has already determined that this type of testingis necessary for a particular material before consulting thisguide.The recommendations of Practice F748 should beconsidered before a study is commenced.1.3 Whenever possible,it is recommended that a battery ofgenotoxicity procedures be initiated and proposed as an alter-native to an in-vivo tumorigenicity bioassay.Genotoxicityassays may also be considered as initial screening proceduresdue to the sensitivity of the assays,the significant reduction intime to gain valuable data,and the desire to reduce the use ofanimals for testing.Genotoxicity assays that may be consid-ered are outlined in Guides E1262,E1263,E1280,and E2186,and Practices E1397 and E1398.Additionally,other genotox-icity testing which might be considered(but which do not yethave ASTM test methods)include Salmonella/Mammalian-Microsomal Plate Incorporation Mutagenicity Assay,In VivoCytogenetics Bone Marrow Chromosomal Damage Assay,BALB/3T3 Morphological Transformation of Mouse EmbryoCells,and the Mouse Micronucleus Assay.The investigator isadvised to consider carefully the appropriateness of a particularmethod for his application after a review of the publishedliterature.1.4 This standard does not purport to address all of thesafety concerns,if any,associated with its use.It is theresponsibility of the user of this standard to establish appro-priate safety,health,and environmental practices and deter-mine the applicability of regulatory limitations prior to use.1.5 This international standard was developed in accor-dance with internationally recognized principles on standard-ization established in the Decision on Principles for theDevelopment of International Standards,Guides and Recom-mendations issued by the World Trade Organization TechnicalBarriers to Trade(TBT)Committee.2.Referenced Documents2.1 ASTM Standards:2E1262 Guide for Performance of Chinese Hamster OvaryCell/Hypoxanthine Guanine Phosphoribosyl TransferaseGene Mutation AssayE1263 Guide for Conduct of Micronucleus Assays in Mam-malian Bone Marrow Erythrocytes(Withdrawn 2014)3E1280 Guide for Performing the Mouse Lymphoma Assayfor Mammalian Cell Mutagenicity(Withdrawn 2014)3E1397 Practice for In Vitro Rat Hepatocyte DNA RepairAssay(Withdrawn 2013)3E1398 Practice for In Vivo Rat Hepatocyte DNA RepairAssay(Withdrawn 2013)3E2186 Guide for Determining DNA Single-Strand Damagein Eukaryotic Cells Using the Comet AssayF748 Practice for Selecting Generic Biological Test Methodsfor Materials and Devices2.2 Other Documents:National Toxicology Program General Statement of Workfor the Conduct of Toxicity and Carcinogenicity Studies inLaboratory Animals4OECD Guidelines for Testing of Chemicals:Guideline 451,1This guide is under the jurisdiction of ASTM Committee F04 on Medical andSurgical Materials and Devices and is the direct responsibility of SubcommitteeF04.16 on Biocompatibility Test Methods.Current edition approved Feb.1,2018.Published April 2018.Originallyapproved in 1992.Last previous edition approved in 2013 as F1439 03(2013).DOI:10.1520/F1439-03R18.2For referenced ASTM standards,visit the ASTM website,www.astm.org,orcontact ASTM Customer Service at serviceastm.org.For Annual Book of ASTMStandards volume information,refer to the standards Document Summary page onthe ASTM website.3The last approved version of this historical standard is referenced onwww.astm.org.4Available from National Institute of Environmental Health Sciences,111 T.W.AlexanderDrive,ResearchTrianglePark,NC,August1988.http:/www.niehs.nih.gov/.Copyright ASTM International,100 Barr Harbor Drive,PO Box C700,West Conshohocken,PA 19428-2959.United StatesThis international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for theDevelopment of International Standards,Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade(TBT)Committee.1